Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Whitehawk Therapeutics, Inc.
WHWK
Other
Executive Educational Background Disclosure
Non Employee Director Compensation Disclosed
Classified Board Director Election
Kol Endorsement
Director Officer Indemnification Provision
Core
Lead Asset Progress
Indication Expansion
Other
Depreciation Expense Composition Disclosure
Net Loss Reported
Liquidity Position Snapshot Disclosed
Financing Activities Cash Flow Disclosure
Institutional Investment
Personnel Cost Decrease Disclosure
Other Income Expense Disclosure
Cash Flow Statement Investing Activities
Sga Expense Comparison Disclosed
Operating Lease Rent Expense Disclosed
Stock Option Intrinsic Value Disclosure
Administrative Efficiency
Ipo Net Proceeds Disclosure
Core
Regulatory Designation Only
Enrollment Failure
Other
Net Loss Reported
Liquidity Position Snapshot Disclosed
Quarterly Performance Praise
Enrollment Ahead Of Schedule
Publication Positive
Interim Data Positive
Core
Patient Enrollment Velocity
Lead Asset Progress
Clinical Trial Result
Combination Therapy Mentioned
Biotech v3
Ind Submission Planned
Other
Auditor Appointment Ratification
Say On Pay Vote Result Disclosed
Other
Interim Data Positive
Safety Differentiated
Fast Track Designation Received
Publication Positive
Fast Track Granted
Core
Clinical Trial Result
Lead Asset Progress
Clinical Hold
Indication Expansion
Biotech v3
Ind Submission Planned
Biotech Risk
Clinical Hold Active
Other
Fcpa Compliance Representation
Corporate Organization And Standing Representation
Conflicted Defense Counsel Provision
Indemnification Consent Requirement
Cause For Termination Defined
Market Price Definition
Exchange Offer Letter Of Transmittal
Closing Deliverables Specified
Survival Of Representations Warranties Clause
Use Of Proceeds Disclosure
Amendment Modification Waiver Clause
Material Weakness Internal Controls
No Broker Fees Representation
Institutional Investment
Power Of Attorney Disclosure
Other
Restructuring Charge Disclosed
Depreciation Expense Composition Disclosure
Liquidity Position Snapshot Disclosed
Deferred Tax Asset Valuation Disclosure
Institutional Investment
Net Loss Reported
Warrant Valued Black Scholes
Other Income Expense Disclosure
Financing Activities Cash Flow Disclosure
Ipo Net Proceeds Disclosure
Rsu Psu Vesting Schedule Disclosed
Personnel Cost Decrease Disclosure
Segment Aggregation Disclosure
Sga Expense Comparison Disclosed
Equity Plan Share Reserve Disclosure
Other
Net Loss Reported
Liquidity Position Snapshot Disclosed
Interim Data Positive
Kol Endorsement
Safety Differentiated
Core
Clinical Trial Result
Lead Asset Progress
Combination Therapy Mentioned
Biotech v3
Ind Submission Planned